2005 Publications

Publications resulting from human brain tissue obtained from the ABBN.

Aoki-Suzuki M, Yamada K, Meerabux J, Iwayama-Shigeno Y, Ohba H, Iwamoto K, Takao H, Toyota T, Suto Y, Nakatani N, Dean B, Nishimura S, Seki K, Kato T, Itohara S, Nishikawa T, and Yoshikawa T. (2005) A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia. Biol Psychiatry. 57: 382-393.


Bergeson SE, Berman AE, Dodd PR, Edenberg HJ, Hitzemann RJ, Lewohl JM, Lodowski KH, and Sommer WH. (2005) Expression profiling in alcoholism research. Alcohol Clin Exp Res. 29: 1066-1073.


Broe M, Shepherd CE, Mann DM, Milward EA, Gai WP, Thiel E, and Halliday GM. (2005) Insoluble α-synuclein in Alzheimer's disease without Lewy body formation. Neurotox Res. 7: 69-76.


Cai Z, Manavis J, Cash K, Thompson PD, and Blumbergs PC. (2005) Immunohistochemical staining of epoxy resin sections of peripheral nerve. Appl Immunohistochem Mol Morphol. 13: 292-294.


Cappai R, Leck SL, Tew DJ, Williamson NA, Smith DP, Galatis D, Sharples RA, Curtain CC, Ali FE, Cherny RA, Culvenor JG, Bottomley SP, Masters CL, Barnham KJ, and Hill AF (2005) Dopamine promotes α-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB J. 19: 1377-1379.


Crews FT, Buckley T, Dodd PR, Ende G, Foley N, Harper C, He J, Innes D, Loh el W, Pfefferbaum A, Zou J, and Sullivan EV. (2005) Alcoholic neurobiology: changes in dependence and recovery. Alcohol Clin Exp Res. 29: 1504-1513.


Crouch PJ, Blake R, Duce JA, Ciccotosto GD, Li QX, Barnham KJ, Curtain CC, Cherny RA, Cappai R, Dyrks T, Masters CL, and Trounce IA. (2005) Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1-42. J Neurosci. 25: 672-679.


Cullen KM, Kocsi Z, and Stone J (2005) Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex. J Cereb Blood Flow Metab. 25: 1656-1667.


Dean B, Keriakous D, Thomas E, and Scarr E. (2005) Understanding the pathology of schizophrenia: the impact of high-throughput screening of the genome and proteome in postmortem CNS. Current Psychiatry Reviews. 1: 1-9.


Dean B, Scarr E, and McLeod M. (2005) Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder. Brain Res Mol Brain Res. 138: 145-155.


Depaz IM, de Las Heras R, Kroon PA, and Wilce PA. (2005) Changes in neuronal protein 22 expression and cytoskeletal association in the alcohol-dependent and withdrawn rat brain. J Neurosci Res. 81: 253-260.


Dickson TC, Chuckowree JA, Chuah MI, West AK, and Vickers JC. (2005) α-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the β-amyloid plaques in inducing neuronal injury. Neurobiol Dis. 18: 286-295.


Digney A, Keriakous D, Scarr E, Thomas E, and Dean B. (2005) Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder. Biol Psychiatry. 57: 711-715.


Eyles DW, Smith S, Kinobe R, Hewison M, and McGrath JJ. (2005) Distribution of the vitamin D receptor and 1 α-hydroxylase in human brain. J Chem Neuroanat. 29: 21-30.


Fedorow H, Tribl F, Halliday G, Gerlach M, Riederer P, and Double KL. (2005) Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease. Prog Neurobiol. 75: 109-124.


Flatscher-Bader T, van der Brug M, Hwang JW, Gochee PA, Matsumoto I, Niwa S, and Wilce PA. (2005) Alcohol-responsive genes in the frontal cortex and nucleus accumbens of human alcoholics. J Neurochem. 93: 359-370.


Gibson JH, Williamson SL, Arbuckle S, and Christodoulou J. (2005) X chromosome inactivation patterns in brain in Rett syndrome: implications for the disease phenotype. Brain Dev. 27: 266-270.


Graham A, Davies R, Xuereb J, Halliday G, Kril J, Creasey H, Graham K, and Hodges J. (2005) Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain. 128: 597-605.


Guerrini I, Thomson AD, Cook CC, McQuillin A, Sharma V, Kopelman M, Reynolds G, Jauhar P, Harper C, and Gurling HM. (2005) Direct genomic PCR sequencing of the high affinity thiamine transporter (SLC19A2) gene identifies three genetic variants in Wernicke Korsakoff syndrome (WKS). Am J Med Genet B Neuropsychiatr Genet. 137B: 17-19.


Guillemin GJ, Brew BJ, Noonan CE, Takikawa O, and Cullen KM. (2005) Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus. Neuropathology and applied neurobiology. 31: 395-404.


Guillemin GJ, Smythe G, Takikawa O, and Brew BJ. (2005) Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia. 49: 15-23.


Harper C, and Matsumoto I. (2005) Ethanol and brain damage. Curr Opin Pharmacol. 5: 73-78.


Harper C, Matsumoto L, Pfefferbaum A, Adalsteinsson E, Sullivan EV, Lewohl J, Dodd P, Taylor M, Fein G, and Landman B. (2005) The pathophysiology of 'brain shrinkage' in alcoholics - Structural and molecular changes and clinical implications. Alcohol Clin Exp Res. 29: 1106-1115.


Ito M, Depaz I, Wilce P, Suzuki T, Niwa S, and Matsumoto I. (2005) Expression of human neuronal protein 22, a novel cytoskeleton-associated protein, was decreased in the anterior cingulate cortex of schizophrenia. Neurosci Lett. 378: 125-130.


Jones AL, Mowry BJ, Pender MP, and Greer JM. (2005) Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol. 83: 9-17.


Lawson VA, Collins SJ, Masters CL, and Hill AF. (2005) Prion protein glycosylation. J Neurochem. 93: 793-801.


Lewohl JM, Wixey J, Harper CG, and Dodd PR. (2005) Expression of MBP, PLP, MAG, CNP, and GFAP in the Human Alcoholic Brain. Alcohol Clin Exp Res. 29: 1698-1705.


Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, Hojrup P, Moos T, Otzen D, Gai WP, Blumbergs PC, and Jensen PH. (2005) p25α stimulates α-synuclein aggregation and is co-localized with aggregated α-synuclein in α-synucleinopathies. The Journal of biological chemistry. 280: 5703-5715.


Matsumoto I, Inoue Y, Iwazaki T, Pavey G, and Dean B. (2005) 5-HT2A and muscarinic receptors in schizophrenia: a postmortem study. Neurosci Lett. 379: 164-168.


Maynard CJ, Bush AI, Masters CL, Cappai R, and Li QX. (2005) Metals and amyloid-β in Alzheimer's disease. Int J Exp Pathol. 86: 147-159.


Newell KA, Zavitsanou K, and Huang XF. (2005) Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients. Neuroreport. 16: 1363-1367.


Noda K, Kitami T, Gai WP, Chegini F, Jensen PH, Fujimura T, Murayama K, Tanaka K, Mizuno Y, and Hattori N. (2005) Phosphorylated IκBα is a component of Lewy body of Parkinson's disease. Biochem Biophys Res Commun. 331: 309-317.


Pamphlett R, Kum-Jew S, and King NJ. (2005) Flaviviruses in motor neuron disease. Muscle Nerve. 32: 108-109.


Panegyres PK, Kwok JB, Schofield PR, and Blumbergs PC. (2005) A Western Australian kindred with Dutch cerebral amyloid angiopathy. J Neurol Sci. 239: 75-80.


Pountney DL, Chegini F, Shen X, Blumbergs PC, and Gai WP. (2005) SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy. Neurosci Lett. 381: 74-79.


Pountney DL, Treweek TM, Chataway T, Huang Y, Chegini F, Blumbergs PC, Raftery MJ, and Gai WP. (2005) α B-crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy. Neurotox Res. 7: 77-85.


Pountney DL, Voelcker NH, and Gai WP. (2005) Annular α-synuclein oligomers are potentially toxic agents in α-synucleinopathy. Hypothesis. Neurotox Res. 7: 59-67.


Ryabinin AE, Tsivkovskaia NO, and Ryabinin SA. (2005) Urocortin 1-containing neurons in the human Edinger-Westphal nucleus. Neuroscience. 134: 1317-1323.


Scarr E, Beneyto M, Meador-Woodruff JH, and Deans B. (2005) Cortical glutamatergic markers in schizophrenia. Neuropsychopharmacology. 30: 1521-1531.


Short CL, Scott G, Blumbergs PC, and Koblar SA. (2005) A case of presumptive primary lateral sclerosis with upper and lower motor neurone pathology. J Clin Neurosci. 12: 706-709.


Sundram S, Copolov D, and Dean B. (2005) Clozapine decreases [3H] CP 55940 binding to the cannabinoid1 receptor in the rat nucleus accumbens. Naunyn Schmiedebergs Arch Pharmacol. 371: 428-433.


Tsai VW, Dodd PR, and Lewis RJ. (2005) The effects of alanine-substituted conantokin-G and ifenprodil on the human spermine-activated N-methyl-D-aspartate receptor. Neuroscience. 130: 457-464.


Tsai VW, Scott HL, Lewis RJ, and Dodd PR. (2005) The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease. Neurotox Res. 7: 125-141.


Villemagne VL, Rowe CC, Macfarlane S, Novakovic KE, and Masters CL. (2005) Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease. J Clin Neurosci. 12: 221-230.


Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, Merlini G, Saraiva MJ, and Sipe JD. (2005) Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid. 12: 1-4.


Williams SM, Sullivan RK, Scott HL, Finkelstein DI, Colditz PB, Lingwood BE, Dodd PR, and Pow DV. (2005) Glial glutamate transporter expression patterns in brains from multiple mammalian species. Glia. 49: 520-541.